Hudson Valley Investment Advisors Inc Eli Lilly & CO Transaction History

Hudson Valley Investment Advisors Inc

  • $903 Million
  • Q3 2024

A detailed history of Hudson Valley Investment Advisors Inc transactions in Eli Lilly & CO stock. As of the latest transaction made, Hudson Valley Investment Advisors Inc holds 48,316 shares of LLY stock, worth $37.1 Million. This represents 4.74% of its overall portfolio holdings.

Number of Shares
48,316
Previous 52,520 8.0%
Holding current value
$37.1 Million
Previous $47.6 Million 9.98%
% of portfolio
4.74%
Previous 5.85%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 25, 2024
SELL
$772.14 - $960.02 $3.25 Million - $4.04 Million
-4,204 Reduced 8.0%
48,316 $42.8 Million
Q2 2024

Jul 02, 2024
BUY
$724.87 - $909.04 $818,378 - $1.03 Million
1,129 Added 2.2%
52,520 $47.6 Million
Q1 2024

Apr 12, 2024
BUY
$592.2 - $792.28 $652,012 - $872,300
1,101 Added 2.19%
51,391 $40 Million
Q4 2023

Jan 12, 2024
SELL
$525.19 - $619.13 $784,108 - $924,361
-1,493 Reduced 2.88%
50,290 $29.3 Million
Q3 2023

Oct 27, 2023
SELL
$434.7 - $599.3 $265,167 - $365,573
-610 Reduced 1.16%
51,783 $27.8 Million
Q2 2023

Jul 17, 2023
SELL
$350.74 - $468.98 $695,166 - $929,518
-1,982 Reduced 3.65%
52,393 $24.6 Million
Q1 2023

Apr 06, 2023
BUY
$310.63 - $364.82 $236,700 - $277,992
762 Added 1.42%
54,375 $18.7 Million
Q4 2022

Jan 31, 2023
SELL
$321.55 - $374.67 $499,045 - $581,487
-1,552 Reduced 2.81%
53,613 $19.6 Million
Q3 2022

Oct 11, 2022
SELL
$296.48 - $337.87 $66,708 - $76,020
-225 Reduced 0.41%
55,165 $17.8 Million
Q2 2022

Jul 18, 2022
SELL
$278.73 - $327.27 $147,726 - $173,453
-530 Reduced 0.95%
55,390 $18 Million
Q1 2022

Apr 20, 2022
BUY
$234.69 - $291.66 $14,785 - $18,374
63 Added 0.11%
55,920 $16 Million
Q4 2021

Jan 24, 2022
SELL
$224.85 - $279.04 $116,472 - $144,542
-518 Reduced 0.92%
55,857 $15.4 Million
Q3 2021

Oct 26, 2021
SELL
$221.6 - $272.71 $238,884 - $293,981
-1,078 Reduced 1.88%
56,375 $13 Million
Q2 2021

Jul 07, 2021
SELL
$180.55 - $233.54 $376,807 - $487,397
-2,087 Reduced 3.51%
57,453 $13.2 Million
Q1 2021

Apr 23, 2021
SELL
$164.32 - $212.72 $271,128 - $350,988
-1,650 Reduced 2.7%
59,540 $11.1 Million
Q4 2020

Jan 15, 2021
BUY
$130.46 - $172.63 $170,511 - $225,627
1,307 Added 2.18%
61,190 $10.3 Million
Q3 2020

Oct 13, 2020
BUY
$146.22 - $169.13 $17,546 - $20,295
120 Added 0.2%
59,883 $8.86 Million
Q2 2020

Jul 07, 2020
BUY
$136.42 - $164.18 $27,011 - $32,507
198 Added 0.33%
59,763 $9.81 Million
Q1 2020

Apr 29, 2020
SELL
$119.05 - $147.35 $928,470 - $1.15 Million
-7,799 Reduced 11.58%
59,565 $8.26 Million
Q4 2019

Jan 17, 2020
BUY
$106.92 - $132.43 $154,285 - $191,096
1,443 Added 2.19%
67,364 $8.85 Million
Q3 2019

Oct 18, 2019
BUY
$106.79 - $116.16 $58,734 - $63,888
550 Added 0.84%
65,921 $7.37 Million
Q2 2019

Jul 16, 2019
BUY
$110.79 - $129.32 $673,935 - $786,653
6,083 Added 10.26%
65,371 $7.24 Million
Q1 2019

Apr 10, 2019
SELL
$111.31 - $131.02 $1,669 - $1,965
-15 Reduced 0.03%
59,288 $7.69 Million
Q4 2018

Jan 17, 2019
BUY
$105.9 - $118.64 $144,871 - $162,299
1,368 Added 2.36%
59,303 $6.86 Million
Q3 2018

Oct 12, 2018
BUY
$85.86 - $107.31 $11,333 - $14,164
132 Added 0.23%
57,935 $6.22 Million
Q2 2018

Jul 10, 2018
BUY
$75.7 - $86.88 $95,003 - $109,034
1,255 Added 2.22%
57,803 $4.93 Million
Q1 2018

Apr 12, 2018
BUY
$74.21 - $87.6 $12,244 - $14,453
165 Added 0.29%
56,548 $4.38 Million
Q4 2017

Jan 16, 2018
BUY
$81.94 - $87.89 $35,643 - $38,232
435 Added 0.78%
56,383 $4.76 Million
Q3 2017

Oct 13, 2017
BUY
$77.07 - $85.54 $4.31 Million - $4.79 Million
55,948
55,948 $4.79 Million

Others Institutions Holding LLY

# of Institutions
4,011
Shares Held
751M
Call Options Held
8.27M
Put Options Held
10.5M
View Full List

About ELI LILLY & Co

LLY Quotes by TradingView
  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $730B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Hudson Valley Investment Advisors Inc Portfolio

Follow Hudson Valley Investment Advisors Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Hudson Valley Investment Advisors Inc , based on Form 13F filings with the SEC.

News

Stay updated on Hudson Valley Investment Advisors Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email